Open Orphan plc changed its name to hVIVO plc on 26 October 2022, learn more here.
Open Orphan plc changed its name to hVIVO plc on 26 October 2022, learn more here.
In the wake of the COVID-19 pandemic, research into infectious diseases remains an integral and growing avenue of clinical research. What benefits can Human Challenge Trials have for clinicians exploring such diseases?
